Company intelligence / Profile preview

Infinite Epigenetics

Boise, Idaho, United States

Ownership: Private
Development stage: Other

Overview

Infinite Epigenetics is a health technology company specializing in epigenetic testing and personalized wellness. The company utilizes DNA methylation analysis to provide insights into biological aging, cellular health, and disease risk. By offering diagnostic tools that measure epigenetic markers, Infinite Epigenetics aims to empower individuals and healthcare providers with actionable data to optimize longevity and preventive care. Their services are primarily focused on the consumer and clinical diagnostic markets, providing a comprehensive view of an individual's health at the molecular level.

Therapeutic areas: Metabolic DisordersOther
Modalities: DNA Methylation Analysis
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Infinite Epigenetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Infinite Epigenetics.

Explore the full profile